Next Article in Journal
Raman Spectroscopy for Early Detection of Cervical Cancer, a Global Women’s Health Issue—A Review
Next Article in Special Issue
Supermolecule—Drug Conjugates Based on Acid-Degradable Polyrotaxanes for pH-Dependent Intracellular Release of Doxorubicin
Previous Article in Journal
A Novel Based Synthesis of Silver/Silver Chloride Nanoparticles from Stachys emodi Efficiently Controls Erwinia carotovora, the Causal Agent of Blackleg and Soft Rot of Potato
Previous Article in Special Issue
Antibacterial Porous Systems Based on Polylactide Loaded with Amikacin
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 28
Issue 6
10.3390/molecules28062501
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Electrospun Polycaprolactone/Chitosan Nanofibers Containing Cordia myxa Fruit Extract as Potential Biocompatible Antibacterial Wound Dressings

by
Amal A. Alyamani
1,
Mastafa H. Al-Musawi
2,
Salim Albukhaty
3,4,*,
Ghassan M. Sulaiman
5,*,
Kadhim M. Ibrahim
6,
Elsadig M. Ahmed
7,8,
Majid S. Jabir
5,
Hassan Al-Karagoly
9,
Abed Alsalam Aljahmany
10 and
Mustafa K. A. Mohammed
11
1
Department of Biotechnology, College of Science, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia
2
Department of Clinical Laboratory Science, College of Pharmacy, University of Al-Mustansiriyah, Baghdad 14022, Iraq
3
Department of Chemistry, College of Science, University of Misan, Amarah 62001, Iraq
4
College of Medicine, University of Warith Al-Anbiyaa, Karbala 56001, Iraq
5
Division of Biotechnology, Department of Applied Sciences, University of Technology, Baghdad 10066, Iraq
6
Department of Plant Biotechnology, College of Biotechnology, Al-Nahrain University, Baghdad 64074, Iraq
7
Department of Medical Laboratories, College of Applied Medical Sciences, University of Bisha, P.O. Box 551, Bisha 61922, Saudi Arabia
8
Department of Clinical Chemistry, Faculty of Medical Laboratory Sciences, University of El Imam El Mahdi, P.O. Box 27711, Kosti 209, Sudan
9
Department of Internal and Preventive Medicine, College of Veterinary Medicine, University of Al-Qadisiyah, Al-Diwaniyah 58002, Iraq
10
Department of Medical Basic Sciences, College of Applied Medical Sciences, University of Bisha, P.O. Box 551, Bisha 61922, Saudi Arabia
11
Radiological Techniques Department, Al-Mustaqbal University College, Hillah 51001, Iraq
 
add Show full affiliation list
 
remove Hide full affiliation list
*
Authors to whom correspondence should be addressed.
Molecules 2023, 28(6), 2501; https://doi.org/10.3390/molecules28062501
Submission received: 15 February 2023 / Revised: 7 March 2023 / Accepted: 7 March 2023 / Published: 9 March 2023
(This article belongs to the Special Issue Polymers in Biomedical Applications)
Browse Figures
Review Reports Versions Notes

Abstract

:
The goal of the current work was to create an antibacterial agent by using polycaprolactone/chitosan (PCL/CH) nanofibers loaded with Cordia myxa fruit extract (CMFE) as an antimicrobial agent for wound dressing. Several characteristics, including morphological, physicomechanical, and mechanical characteristics, surface wettability, antibacterial activity, cell viability, and in vitro drug release, were investigated. The inclusion of CMFE in PCL/CH led to increased swelling capability and maximum weight loss. The SEM images of the PCL/CH/CMFE mat showed a uniform topology free of beads and an average fiber diameter of 195.378 nm. Excellent antimicrobial activity was shown towards Escherichia coli (31.34 ± 0.42 mm), Salmonella enterica (30.27 ± 0.57 mm), Staphylococcus aureus (21.31 ± 0.17 mm), Bacillus subtilis (27.53 ± 1.53 mm), and Pseudomonas aeruginosa (22.17 ± 0.12 mm) based on the inhibition zone assay. The sample containing 5 wt% CMFE had a lower water contact angle (47 ± 3.7°), high porosity, and high swelling compared to the neat mat. The release of the 5% CMFE-loaded mat was proven to be based on anomalous non-Fickian diffusion using the Korsmeyer–Peppas model. Compared to the pure PCL membrane, the PCL-CH/CMFE membrane exhibited suitable cytocompatibility on L929 cells. In conclusion, the fabricated antimicrobial nanofibrous films demonstrated high bioavailability, with suitable properties that can be used in wound dressings.

1. Introduction

The skin acts as a physical barrier to keep germs out of possible infection sites in living beings. However, traumas such as fractures, heat burns, lacerations, or surgical incisions can damage the skin’s structure and function and occasionally cause the skin to lose its protective function due to a disruption in the tissue’s healthy relationship caused by wounds [1,2]. Local antibacterial and dressing therapies are widely utilized to reduce drug resistance in the case of treatment with systemic antibiotics [3]. Additionally, wound healing is a complex process that includes epithelialization, matrix deposition, cell proliferation, tissue regeneration, and inflammation [4]. As a result, the optimal dressing should be moisturizing and breathable, absorb exudate, have anti-inflammatory, antibacterial, and antioxidative properties, and encourage cell proliferation and wound healing [5,6,7]. Due to their adjustable nanostructures and functionalities, nanomaterials, including the bactericidal performance of nanoparticles (NPs) and nanofibers, have recently received a significant promotion for the treatment of wounds [8,9,10,11,12]. Nanofibers are among the nanomaterials mentioned above that have high specific surface areas, microscopic pore diameters, moisturizing qualities, the capacity to allow air exchange, and morphologies that resemble the extracellular matrix; these features make nanofibers attractive options for wound dressings [13,14].
A remarkable method for producing nanofibers on a large scale from a polymer suspension is electrospinning. Under the influence of an electric field, electrospun fibers may be spun to nanoscale sizes [15,16]. Numerous natural and synthetic polymers have been electrospun into fibers, which have tremendous potential for medication delivery for the treatment of burn injuries [17]. Due to its appropriate mechanical behavior and biocompatibility, polycaprolactone (PCL), a biodegradable, stable, and non-hazardous synthetic polymer has been widely used in electrospun nanofiber membranes [18,19]. However, due to their hydrophobic properties, monomer PCL nanofibers may not be the best substrate for promoting cell growth and migration [20]. To enhance the surface-wetting capability of nanofibers, varieties of hydrophilic materials have been combined with PCL. Chitosan (CH) is a natural polysaccharide with biodegradable, biocompatible, and non-toxic properties and is thus proposed to be a safer substrate for use in biomedical applications, such as tissue engineering, the delivery of pharmaceutical drugs, and as wound dressings [21,22,23]. Chitosan has been studied extensively as a wound dressing because it can serve as a promoter of proliferation, an antibacterial agent, and an activator of macrophages [24]. Moreover, the inclusion of CH in PCL nanofibers may enhance the surface hydrophilicity of scaffolds [25].
The Cordia myxa tree, also known as “Bamber” in Iraq, was discovered to contain highly bioactive compounds. Cordia myxa can be used to treat respiratory tract infections as an expectorant and demulcent and can also act as a diuretic and anti-diarrheal medication. The compounds isolated from the genus Cordia have been identified as having antiviral, tumor cell cytotoxic, anti-inflammatory, and free radical scavenging properties [26,27,28,29]. Here, we propose that Cordia myxa fruit, by its antioxidant and antimicrobial properties, could eliminate chemicals such as reactive oxygen species generated via inflammatory responses and minimize the slow healing of wounds caused by infection. Herein, Cordia myxa fruit extract was loaded into poly(-caprolactone) chitosan-based nanofibrous mats to improve antimicrobial efficacy and biocompatibility for accelerated wound healing. SEM, XRD, and FT-IR studies of the morphological and structural properties of the fabricated nanofibers and their surface wettability, water absorption, and weight loss were also characterized. MTT assays on the L929 cell line were performed to assess the cytotoxicity. In addition, antibacterial properties against Escherichia coli, Salmonella enterica, Staphylococcus aureus, Bacillus subtilis, and Pseudomonas aeruginosa were studied via the inhibition zone test, which implied that the obtained PCL-CH/CMFE is a promising wound dressing for skin injuries.

2. Results and Discussion

The current study focused on CMF fruit extracts stabilized on polycaprolactone/chitosan nanofibers for medical uses, such as antimicrobial properties for wound dressing applications. The rationale behind immobilizing plant materials with pharmacological significance, particularly for healing wounds, on a polymer matrix is fascinating [30]. The polymer matrix can encourage properties such as chemical and antimicrobial effectiveness to the plant extracts owing to its small size and surface area-to-volume ratio. Electrospinning was utilized to prepare PCL/CH nanofibrous scaffolds in the current study, where the CMF extract was immobilized into the created nanofibers. In spite of the fact that medicinal CMF extract has notable wound healing and antibacterial actions, it is preferable to improve them via immobilizing the extract on the nanofibrous surface of a scaffolding [31]. Electrospinning polymer nanofibers of PCL/CH containing a varied quantity of CMF extract was performed according to the criteria outlined in the methods section. Table 1 summarizes the composites and electrospinning parameters that were employed to create the samples.
Figure 1 reveals SEM micrographs of PCL/CH electrospun nanofibers and CMF fruit extract-loaded PCL/CH nanofibers that showed a nano-scaled fibrous architecture without the existence of beads. This was obtained by utilizing the optimal spinning conditions used in this research. Round-shaped PCL nanofiber scaffolds with a smooth surface are optimum characteristics. Since plant extracts induce clusters to develop at branching points, a uniform fiber surface appears to be essential, even though the fiber diameter of the CMF-PCL/CH nanofiber scaffolds did not change significantly. However, due to the immobilization of the extract, the SEM micrographs of the CMF extract-loaded fibers seem to have a slightly swollen morphology. The diameter size of fibers was calculated using ImageJ, and it was shown to be in the range of 97 ± 7 nm for PCL nanofibers. CH tends to make the electrospinning suspension more polar due to its charged functional groups that cause fibers to stretch in an electrical field [32]. The diameter of PCL/CH fibers was 197 ± 23 nm, while the diameter of CH/PCL/CMF fibers was 295 ± 78 nm, with a slight increase due to swelling.
To demonstrate the crystalline structure of CMFE-loaded PCL/CH nanofibers, X-ray diffraction (XRD) was investigated. XRD showed that the electrospun nanofibers contained crystals (Figure 2). The solvent medium, parameters, applied voltage, and polymer characteristics (molecular weight) all affect the crystal structure [33]. XRD was taken to analyze the modifications in the crystalline structure of the pristine electrospun PCL/CH/CMF nanofiber membrane. This is demonstrated in Figure 2. Two diffraction peaks at transmittance angles of 21.4° and 23.8° were observed in both cases, which were related to the semi-crystalline behavior of PCL [34,35,36].
The FTIR test was employed to investigate the functional groups found in PCL, CH, CMFE, and PCL/CH/CMFE (Figure 3). The pure PCL membrane had characteristic peaks at 2938, 2865, 1730,1408, 1106, and 730 cm−1, which are related to the (CH2), (CH2), (C=O), (CH2), (O-C), and (CH2) vibrations [37]. The FTIR spectra of chitosan showed peaks at 3440 cm−1, 1636–1650 cm−1, and 1107 cm−1 that contribute to chitosan groups, as stated in the FTIR spectra of chitosan [38]. The broad peak in the spectra of pure CMFE shown in Figure 3 at 3404 cm−1 revealed the existence of both free hydroxyl groups and hydroxyl groups involved in hydrogen bonding. The sharp peak at 1712 cm−1 may be caused by the carbonyl group (C=O), which could also point to the existence of compounds containing carboxylic acid. Similar results suggest that the C. dichotoma fruit extract contains some uronic acid in previous studies [39]. The band at 1434 cm−1 is caused by the C=C stretching vibration in aromatic rings, such as those present in phenolic and flavonoid compounds.
The spectrum of the PCL/CH/CMFE mat (Figure 3) showed no major extra peaks or deviations from the peaks of the pure materials. This confirmed that CFE remained mostly intact and unreacted within the nanofibers. The PCL/CH/CMFE spectrum, as shown in Figure 3, suggests that there were no significant extra peaks or changes from the peaks of the pure materials. This confirmed that CMFE was mostly unreacted and retained inside the fibers.
Stress–strain profiles exhibit two nanofiber samples made from pure PCL 12 w/v and PCL/CH/CMF 5% volume ratios of 70/30 (Figure 4A and Table 2). Adding the natural polymer to the scaffold reduces its mechanical strength. Lower fiber strength is detected in the sample containing 12% PC, in addition to enhanced flexibility and elongation. PCL/CH/CMFE 3% membranes presented a stress (MPa) of 20.1107 in a dry state, whereas PCL demonstrated 24.8931 MPa under the same conditions (Figure 4B).
The mechanical behavior of wet membrane scaffolds was examined after being immersed in phosphate-buffered saline (PBS) for 24 h, and standard stress–strain curves were produced utilizing standard tensile stress–strain testing (Figure 4). Table 2 demonstrates that the PCL’s extension, thickness, tensile modulus, and stress were reduced by the addition of CH and CMFE. The PCL has 69.2% porosity, while the PCL/CH/CMFE has 76.9%.
Wettability is an essential factor to consider when choosing a wound dressing since it influences cell adherence, proliferation, and the ability to absorb exudates. The water contact angle can be used to determine the wettability of a surface. The water contact angle was measured to determine the behavior of the composite PCL/CH/CMFE mats and assess the hydrophilicity alterations in nanocomposite scaffolds. As presented in Figure 5, results obtained for PCL-12% film exhibit poor hydrophilicity with an average contact angle of 125.5°, which is in line with the hydrophobic nature of the polymer. The contact angle value of PCL decreased to 99.4°, 73°, and 47.4° after the addition of CH at 2%, CMFE at 3%, and CH at 2% + CMFE at 3%, respectively.
It has been demonstrated that greatly swelling matrices promote cell growth, adhesion, and internal migration of scaffolds [39]. Anionic and cationic polyelectrolytes improve the electrical conductivity of the electrospinning solution [40].
The swelling’s capacity to absorb wound exudates keeps the region surrounding the wound dry and reduces the risk of infection. The swelling ratio was increased by the use of CMFE in this study. The swelling behavior of the PCL/CH/CMFE nanofibrous performed better, with values of 101.2 ± 6.1 as compared to the PCL/CH mat, which was 86.7 ± 7.7, as shown in Table 2. The results of the wettability test supported our swelling findings. The incorporation of CH and CMFE within the PCL matrix may present some hydrophilic groups, such as NH and OH, on the surface of the nanocomposite membranes. Therefore, the wettability of the PCL scaffold can be seriously modified by the addition of CH/CMFE nanofiber. The higher hydrophilicity of the resultant scaffold is thought to be due to hydrophilic groups, such as hydroxyl and carboxyl groups, which are present in the CMF structure as identified by the GC-MS test. These findings are in agreement with the result of Allafchian et al., who reported that the contact angle for PCL is 120°, while after the addition of quince seed mucilage, the contact angle value of PCL decreased to about 40° [41].
The in vitro release of CMFE from the PCL/CH fibrous mat is depicted in Figure 6. The release curve showed that larger CMFE concentrations were released at equivalent time points. The PCL/CMFE 3% mats released 94.5% within the first 24 h. Thereafter, the slope of the curves decreased, indicating a more gradual release, which extended to 120 h. The maximum CMFE concentrations after 120 h were 62.1 ± 2.2 μg/mL for the PCL/CMFE 3% mat.
The antibacterial activity of the nanofibrous mat is important for the healing of skin lesions. Therefore, the antibacterial effectiveness of the produced CMFE-loaded PCL/CH nanofibrous mats was examined in this section against the most prevalent bacterial species that cause wound infections, including E. coli, S. Enterica, P. aeruginosa, S. aureus, and B. subtilis. Figure 7 illustrates a PCL/CH scaffold with and without CMFE antibacterial activity. PCL/CH fibers without CMFE extract exhibit antibacterial activity with various inhibition zones against B. subtilis (11.47 mm), S. aureus (12.5 mm), and E. coli, S. enterica, and P. aeruginosa with 22.5 mm, 22.1 mm, and 15.4 mm, respectively. PCL/CH/CMFE demonstrated significant antibacterial activity against S. aureus (21.31 ± 0.17 mm with IZ at 100 mg/mL concentration), E. coli (31.34 ± 0.42 mm), and S. enterica, B. subtilis, and P. aeruginosa (30.27 ± 0.57, 27.53 ± 1.53, and 22.17 ± 0.12 mm, respectively).
As Gram-positive bacteria, S. aureus and B. subtilis are believed to have thicker cell walls and are, therefore, more resistant to action by chitosan than E. coli [42]. Additionally, it has been shown that chitosan has a much stronger affinity toward Gram-negative bacteria in comparison to Gram-positive bacteria [43]. It is well known and has been thoroughly researched that chitosan has antibacterial properties that are connected to its cationic structure, which results from its protonated amine groups when it comes into contact with liquids [44]. It is possible that this is connected to the positively charged NH2 groups of CH, which absorb and desorb negative and positively charged Gram-negative and Gram-positive bacterium, respectively, due to electrostatic forces [45]. It is important to emphasize that CMFE extracts added antibacterial action to chitosan-based nanofibrous mats against Gram-negative bacteria in addition to providing antibacterial activity against Gram-positive bacteria. This is attributed to CMFE’s natural ability to combat E. coli, S. enterica, P. aeruginosa, S. aureus, and B. subtilis [28,46] and its synergistic antimicrobial effect with chitosan against the above pathogens. Thus, the synergistic antibacterial action of PCL/CH-based nanofiber and coupled CMFE exhibited encouraging results to enhance antibacterial wound dressings. Further research is necessary to fully comprehend the mechanism of growth suppression in B. subtilis, S. aureus, E. coli, and S. enterica, as well as the detailed mode of action of the bioactive components of CMFE.
This study showed positive results concerning the antimicrobial activity caused by PCL/CH/CMF to S. aureus, E. coli, S. enterica, B. subtilis, and P. aeruginosa. This corresponds to the previous study conducted by Stasiuk et al., [47] who reported antibacterial activities against S. aureus and E. coli. These results suggest that the ethanol extract of CMF can be utilized to inhibit foodborne diseases caused by microbial pathogens such as S. aureus, E. coli, S. enterica, B. subtilis, and P. aeruginosa. The current results are consistent with the previously published findings of Hamdia et al. [48] on the antibacterial activity of Cordia fruit extracts. These authors showed that C. myxa extracts (aqueous and alcoholic) exhibited concentration-dependent inhibition zones against P. fluorescens, S. enterica, S. dysenteriae, and E. coli. The results suggest that fruit extract could be used to reduce microbial infections caused by S. aureus, E. coli, S. enterica, B. subtilis, P. aeruginosa, A. brasiliensis, and S. cerevisiae.
To evaluate the cytotoxicity of the nanofibers, we performed the MTT test. The viability of cells cultured in various nanofiber suspensions varied, as seen in Figure 8. Compared to the pure PCL membrane, the PCL-CH/CMF membrane exhibited almost negligible cytotoxicity. The enhanced biocompatibility of CMF may have increased cell viability. Results showed that dermal fibroblast cells were not significantly cytotoxic to the nanofiber scaffolds of PCL/CH/CMFE. The PCL/CH/CMFE electrospun nanofibers have improved surface area, density, and pore size characteristics. This occurred by changing critical manufacturing parameters, such as the distance between the needle and collector, electrical voltage, and the volume of the pumped polymer. Nanofibers have grown in importance in biotechnology due to their prospective uses and huge surface area, which might be employed to make a good matrix for biological activity [49]. It is crucial to employ biocompatible chemicals such as CH and CMFE; because of their greater bioactivity compared to synthetic polymers, natural polymers such as CH have demonstrated promising outcomes in vitro and in vivo [50]. Reactive oxygen species (ROS) depletion-based therapeutics like CMFE may help to reduce inflammation and facilitate a smooth transition from the inflammatory to the proliferative phase of the cell cycle. According to earlier research, natural antioxidants such as plant flavonoids may prevent free radical chain reactions or scavenge ROS to reduce the oxidation of cellular components and promote cell development [51]. The specific mechanisms by which CMFE stimulates the production of fibroblast growth factor and cell proliferation are still unknown. According to earlier studies, CMFE interacts with the growth factor receptors on fibroblasts to promote cell activity and proliferation. One of the key hypothesized mechanisms of topical CMFE activity on the wound area was related to the plant extract’s chemotactic action, which may have attracted inflammatory cells in addition to having antimicrobial properties [52].

3. Materials and Methods

3.1. Chemicals

Polycaprolactone (PCL, Mn 80,000 g/mol), chitosan (CH) (≥85% (degree of deacetylation) Mw 100 kDa, acetic acid, and formic acid were purchased from Sigma Aldrich at concentrations of 0.2 M and 0.6 M, respectively. All the compounds employed were of analytical reagent quality and required no further processing.

3.2. Plant Collection and Extraction

Fresh C. myxa fruits (Figure 9) were harvested from trees in Baghdad, Iraq, between July and August 2020, and botanists from Al-Nahrain University confirmed their authenticity. The harvested plant material was packaged in a polyethylene bag to avoid moisture loss during transport to Al-Nahrain University’s Research Center laboratory in Baghdad.
The procedure for C. myxa fruit extract was conducted according to the previously published procedure reported by El-Massry et al. [53]. Briefly, the fruits were cleaned and thoroughly inspected to remove those that were physically or microbiologically damaged. The gathered fruits were cleaned with tap water and passed through a deionized water solution. The harvest was collected, dried in the shade, and then processed into a powder. Then, 100 g of powder was mixed with 250 mL of ethanol in a round-bottom flask utilizing a magnetic stirrer for three hours at 25 °C, and the mixture was filtered under vacuum (using Whatman No. 1 filter paper, Cytiva, NY, USA). The materials of the filter paper were transferred to the conical flask once again, and the procedure was repeated. The extract was pooled and dried using a rotating evaporator. For yield computation, the resultant crude extract was weighed and kept at 4 °C until required. As a solvent for extraction, a 70% ethanolic solution was utilized. In the following studies, the fruit sample was diluted in ethanol at an optimal concentration. The residual material was preserved at −20 °C until further use. All the tests were carried out within 72 h of extraction.

3.3. Electrospun

The electrospinning variables, PCL and CH concentration, were assessed with minimal modifications based on a recently published study [32]. For the electrospun method, the optimum voltage, feeding rate, and distance between the needle and the collector were set at 12 kV, 0.6 mL/h, and 21 cm, respectively, and the fibers were collected using an aluminum sheet. A suspension of 12% PCL, 2% CH, and 5% CMF was prepared separately using a 30/70 solvent mixture of acetic acid and formic acid. Then, a mixture of PCL/CH/CMF in the ratio of 3/1/2 was produced, and it was placed on a magnetic stirrer for 15 h to create a uniform mixture. As-prepared suspensions were placed into a 5 mL plastic syringe, whose nozzle was an 18-gauge stainless steel tip. For the gathering of the nanofibrous mats, several voltages and flow rates were applied to each of the blend suspensions, while the optimal values that produced uniform nanofibers were chosen. A total of 20 cm was maintained between the tip and the collection. Materials were gathered on a ground collector coated in aluminum plates and cotton gauze. During collection, a fixed collecting surface was utilized, while the spinneret moved transversely at 100 mm/s and was 100 mm in diameter.

3.4. Morphological Features

SEM (TESCAN, MRA-3, Brno, Czech Republic) was used to analyze the morphological properties of the CMF/PCL/chitosan scaffold nanofibers, which were coated with an ultrathin 5-nm gold undercurrent and a voltage of 6 kV. XRD at the CuKα wavelength (0.15405 nm) was used to investigate the crystalline phase of CMFE-loaded PCL/CH. The current utilized was 25 mA, while the voltage used was 40 kV.

3.5. FTIR

FTIR (IR Tracer 100, Shimadzu, Japan) measurements in the 500–4000 cm−1 range were used to investigate the functional groups in the nanofiber electrospun samples.

3.6. Porosity

The tensile strength and elasticity of PCL/CH/CMFE were calculated during the examination of scaffold strength. The porosity of the PCL/CH/CMFE composite was determined using the gravimetric approach as in previously published work [25]:
p = 1 − A d   B d   × 100 %
where p indicates porosity, Ad represents the apparent density fibrous mat, and Bd indicates the bulk density fibrous mat.

3.7. Water Contact Angle

The contact angle was dynamically calculated using the Wilhelmy plate approach [54]. The hydrophilicity or hydrophobicity of the sample was tested and evaluated using water with a surface tension of 72 dyn/cm. The liquid in the container increased until the metal plate’s intended surface was completely submerged in water, at which point it began to descend. The formula below can be used to determine the contact angle.
Τ c o s   θ = W s C
where T is the water’s surface tension, θ indicates the water contact angle, Ws indicates the weight shift, and C is the fibrous mat’s diameter.

3.8. The Swelling Test

The swelling level of the PCL/CH/CMFE samples was evaluated in PBS solution at a pH of 7.4 for 2 h at room temperature in accordance with the following relationship:
S t = W s − W d W d × 100 %
where St is the swelling test, Ws is the weight of each sample after it is immersed in the buffer solution for an hour, and Wd is the sample’s initial weight in its dry form.

3.9. CMFE Release Profile

A 1 cm2 piece of CMFE-loaded PCL/CH mat was soaked in 14 mL of pH 7.4 PBS buffer at 37 °C for various times ranging from 1 to 120 h with moderate stirring. To measure the CMFE concentration, a UV spectrophotometer at 280 nm was used with a calibration curve of CMFE at ranges of 0 to 100 µg/mL, and aliquots of the solution (200 μL) were taken at each time point. To maintain the overall volume constant, a fresh 2 µL of PBS was added to the solution after the same volume was removed.

3.10. Antibacterial

S. aureus, E. coli, S. enterica, B. subtilis, and P. aeruginosa were used for the evaluation of PCL/CH/CMFE in this part. The antibacterial activities of PCL/CH scaffolds with and without CMFE were evaluated by a zone inhibition test. Antibacterial activity was tested against E. coli, S. enterica, S. aureus, B. subtilis, and P. aeruginosa. Briefly, the synthetic corneal plates were cut to a diameter of 6 mm. UV light was used to sterilize the plates for one hour. Gentamycin was utilized as a control group, and the disks were cultured for 24 h at 37 °C. The growth inhibition zones were then calculated.

3.11. MTT Assay

The MTT test was carried out on the normal fibroblast cells, L929 cells, in order to evaluate the biocompatibility effect of the PCL/CH/CMF fibrous mat. Briefly, DMEM enriched with 10% fetal bovine serum, streptomycin (100 g/mL), and penicillin (100 U/mL) were used to cultivate the cells. They were then incubated at 37 °C with 5% CO2. Therefore, cells were plated in a multi-well plate with DMEM-soaked fibers at a density of 2.4 × 104 cells per well and incubated for 24, 48, and 72 h. The MTT solution was then incorporated into the media in each well, and the cells were cultivated for an additional 4 h at 37 °C. The final step was dissolving the produced formazan crystals in DMSO and reading the absorbance at 570 nm on a microplate reader.

4. Conclusions

In this study, a novel fibrous scaffold formulation was successfully prepared using electrospun PCL/CH fibers loaded with CMFE and was found to be safe for skin L929 fibroblast cells for use in wound dressing applications. After that, their structure, physicomechanical, antimicrobial, and in vitro characteristics were investigated. SEM analysis revealed thin fibers with mean diameters as low as 197 nm and a bead-free shape. PCL/CH fibers loaded with CMFE showed high porosity, promising tensile strength, enhanced hydrophilicity, and biocompatibility. Furthermore, the incorporation of CMFE in the PCL/CH composite was supported by the chemical analysis of the nanofibrous composite by FTIR spectroscopy and structural XRD data. CMFE-loaded PCL/CH fibers were effective against both Gram-positive (B. subtilis, S. aureus) and Gram-negative (S. enterica, E. coli, and P. aeruginosa) bacteria. The CMFE drug was rapidly released within 24 h. According to the findings, PCL/CH/CMFE electrospun nanofibers demonstrated outstanding promise and had the potential to be employed as wound dressings.

Author Contributions

Conceptualization, A.A.A. (Amal A. Alyamani) and K.M.I.; methodology, M.H.A.-M.; software, M.K.A.M.; validation, M.S.J., G.M.S. and H.A.-K.; formal analysis, A.A.A. (Amal A. Alyamani); investigation, S.A.; resources, M.H.A.-M.; data curation, S.A.; writing—original draft preparation, G.M.S.; writing—review and editing, E.M.A.; visualization, A.A.A. (Abed Alsalam Aljahmany); supervision, S.A.; project administration, K.M.I.; funding acquisition, A.A.A. (Amal A. Alyamani) and H.A.-K. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

The authors extend their appreciation to Taif University, the University of Bisha, Saudi Arabia, the University of Misan, Mayasn, Mustansiriyah University, Al-Nahrain University and the University of Technology, Baghdad, Iraq, for their technical support.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Harris-Tryon, T.A.; Grice, E.A. Microbiota and maintenance of skin barrier function. Science 2022, 376, 940–945. [Google Scholar] [CrossRef] [PubMed]
  2. Nguyen, A.V.; Soulika, A.M. The Dynamics of the Skin’s Immune System. Int. J. Mol. Sci. 2019, 20, 1811. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Baig, M.S.; Banu, A.; Zehravi, M.; Rana, R.; Burle, S.S.; Khan, S.L.; Islam, F.; Siddiqui, F.A.; Massoud, E.E.S.; Rahman, M.H.; et al. An Overview of Diabetic Foot Ulcers and Associated Problems with Special Emphasis on Treatments with Antimicrobials. Life 2022, 12, 1054. [Google Scholar] [CrossRef] [PubMed]
  4. Tottoli, E.M.; Dorati, R.; Genta, I.; Chiesa, E.; Pisani, S.; Conti, B. Skin Wound Healing Process and New Emerging Technologies for Skin Wound Care and Regeneration. Pharmaceutics 2020, 12, 735. [Google Scholar] [CrossRef]
  5. Zhang, K.; Jiao, X.; Zhou, L.; Wang, J.; Wang, C.; Qin, Y.; Wen, Y. Nanofibrous composite aerogel with multi-bioactive and fluid gating characteristics for promoting diabetic wound healing. Biomaterials 2021, 276, 121040. [Google Scholar] [CrossRef]
  6. De Luca, I.; Pedram, P.; Moeini, A.; Cerruti, P.; Peluso, G.; Di Salle, A.; Germann, N. Nanotechnology Development for Formulating Essential Oils in Wound Dressing Materials to Promote the Wound-Healing Process: A Review. Appl. Sci. 2021, 11, 1713. [Google Scholar] [CrossRef]
  7. Nour, S.; Baheiraei, N.; Imani, R.; Khodaei, M.; Alizadeh, A.; Rabiee, N.; Moazzeni, S.M. A review of accelerated wound healing approaches: Biomaterial-assisted tissue remodeling. J. Mater. Sci. Mater. Med. 2019, 30, 120. [Google Scholar] [CrossRef]
  8. Alberti, T.; Coelho, D.S.; Voytena, A.; Pitz, H.; de Pra, M.; Mazzarino, L.; Kuhnen, S.; Ribeiro-do-Valle, R.M.; Maraschin, M.; Veleirinho, B. Nanotechnology: A promising tool towards wound healing. Curr. Pharm. Des. 2017, 23, 3515–3528. [Google Scholar] [CrossRef]
  9. Albukhaty, S.; Al-Karagoly, H.; Dragh, M.A. Synthesis of zinc oxide nanoparticles and evaluated its activity against bacterial isolates. J. Biotech Res. 2020, 11, 47–53. [Google Scholar]
  10. Safat, S.; Buazar, F.; Albukhaty, S.; Matroodi, S. Enhanced sunlight photocatalytic activity and biosafety of marine-driven synthesized cerium oxide nanoparticles. Sci. Rep. 2021, 11, 14734. [Google Scholar] [CrossRef]
  11. Jihad, M.A.; Noori, F.T.M.; Jabir, M.S.; Albukhaty, S.; AlMalki, F.A.; Alyamani, A.A. Polyethylene Glycol Functionalized Graphene Oxide Nanoparticles Loaded with Nigella sativa Extract: A Smart Antibacterial Therapeutic Drug Delivery System. Molecules 2021, 26, 3067. [Google Scholar] [CrossRef] [PubMed]
  12. Croitoru, A.-M.; Ficai, D.; Ficai, A.; Mihailescu, N.; Andronescu, E.; Turculet, S.C. Nanostructured Fibers Containing Natural or Synthetic Bioactive Compounds in Wound Dressing Applications. Materials 2020, 13, 2407. [Google Scholar] [CrossRef] [PubMed]
  13. Al-Kaabi, W.J.; Albukhaty, S.; Al-Fartosy, A.J.M.; Al-Karagoly, H.K.; Al-Musawi, S.; Sulaiman, G.M.; Dewir, Y.H.; Alwahibi, M.S.; Soliman, D.A. Development of Inula graveolens (L.) Plant Extract Electrospun/Polycaprolactone Nanofibers: A Novel Material for Biomedical Application. Appl. Sci. 2021, 11, 828. [Google Scholar] [CrossRef]
  14. Wang, C.; Wang, J.; Zeng, L.; Qiao, Z.; Liu, X.; Liu, H.; Zhang, J.; Ding, J. Fabrication of Electrospun Polymer Nanofibers with Diverse Morphologies. Molecules 2019, 24, 834. [Google Scholar] [CrossRef] [Green Version]
  15. Albukhaty, S.; Al-Karagoly, H.; Allafchian, A.R.; Jalali, S.A.H.; Al-Kelabi, T.; Muhannad, M. Production and characterization of biocompatible nanofibrous scaffolds made of β-sitosterol loaded polyvinyl alcohol/tragacanth gum composites. Nanotechnology 2021, 33, 085102. [Google Scholar] [CrossRef]
  16. Luo, W.L.; Zhang, J.; Qiu, X.; Chen, L.J.; Fu, J.; Hu, P.Y.; Li, X.; Hu, R.J.; Long, Y.Z. Electric-field-modified in situ precise deposition of electrospun medical glue fibers on the liver for rapid hemostasis. Nanoscale Res. Lett. 2018, 13, 278. [Google Scholar] [CrossRef]
  17. Amini, S.; Salehi, H.; Setayeshmehr, M.; Ghorbani, M. Natural and synthetic polymeric scaffolds used in peripheral nerve tissue engineering: Advantages and disadvantages. Polym. Adv. Technol. 2021, 32, 2267–2289. [Google Scholar] [CrossRef]
  18. Malikmammadov, E.; Tanir, T.E.; Kiziltay, A.; Hasirci, V.; Hasirci, N. PCL and PCL-based materials in biomedical applications. J. Biomater. Sci. Polym. Ed. 2018, 29, 863–893. [Google Scholar] [CrossRef]
  19. Kahdim, Q.S.; Abdelmoula, N.; Al-Karagoly, H.; Albukhaty, S.; Al-Saaidi, J. Fabrication of a Polycaprolactone/Chitosan Nanofibrous Scaffold Loaded with Nigella sativa Extract for Biomedical Applications. BioTech 2023, 12, 19. [Google Scholar] [CrossRef]
  20. Ghasemi-Mobarakeh, L.; Prabhakaran, M.P.; Morshed, M.; Nasr-Esfahani, M.H.; Ramakrishna, S. Bio-functionalized PCL nanofibrous scaffolds for nerve tissue engineering. Mater. Sci. Eng. C 2010, 30, 1129–1136. [Google Scholar] [CrossRef]
  21. Tao, F.; Cheng, Y.; Shi, X.; Zheng, H.; Du, Y.; Xiang, W.; Deng, H. Applications of Chitin and Chitosan Nanofibers in Bone Regenerative Engineering. Carbohydr. Polym. 2020, 230, 115658. [Google Scholar] [CrossRef] [PubMed]
  22. Al-Musawi, S.; Albukhaty, S.; Al-Karagoly, H.; Almalki, F. Design and Synthesis of Multi-Functional Superparamagnetic Core-Gold Shell Coated with Chitosan and Folate Nanoparticles for Targeted Antitumor Therapy. Nanomaterials 2020, 11, 32. [Google Scholar] [CrossRef] [PubMed]
  23. Priya, S.; Batra, U.; Samshritha, R.N.; Sharma, S.; Chaurasiya, A.; Singhvi, G. Polysaccharide-based nanofibers for pharmaceutical and biomedical applications: A review. Int. J. Biol. Macromol. 2022, 218, 209–224. [Google Scholar] [CrossRef] [PubMed]
  24. Matica, M.A.; Aachmann, F.L.; Tøndervik, A.; Sletta, H.; Ostafe, V. Chitosan as a wound dressing starting material: Antimicrobial properties and mode of action. Int. J. Mol. Sci. 2019, 20, 5889. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Ghaee, A.; Bagheri-khoulenjani, S.; Afshar, H.A.; Bogheiri, H. Biomimetic nanocomposite scaffolds based on surface modified PCL-nanofibers containing curcumin embedded in chitosan/gelatin for skin regeneration. Compos. Part B 2019, 177, 107339. [Google Scholar] [CrossRef]
  26. Sivalingam, P.N.; Singh, D.; Chauhan, S. Morphological and molecular diversity of an underutilized fruit crop—Cordia myxa L. germplasm from the arid region of Rajasthan, India. Genet. Resour. Crop Evol. 2012, 59, 305–316. [Google Scholar] [CrossRef]
  27. Yaermaimaiti, S.; Wu, T.; Aisa, H.A. Bioassay-guided isolation of antioxidant, antimicrobial, and antiviral constituents of Cordia dichotoma fruits. Ind. Crops Prod. 2021, 172, 113977. [Google Scholar] [CrossRef]
  28. Al-Musawi, M.H.; Ibrahim, K.M.; Albukhaty, S. Phytochemical Analysis, and Anti-Microbial Activities of Ethanol Extract of Cordia myxa Fruit: In vitro Study. Res. J. Pharm. Technol. 2022, 15, 2871–2876. [Google Scholar] [CrossRef]
  29. Al-Musawi, M.H.; Ibrahim, K.M.; Albukhaty, S. In vitro study of antioxidant, antibacterial, and cytotoxicity properties of Cordia myxa fruit extract. Iran. J. Microbiol. 2022, 14, 97–103. [Google Scholar] [CrossRef]
  30. Khandaker, M.; Alkadhem, N.; Progri, H.; Nikfarjam, S.; Jeon, J.; Kotturi, H.; Vaughan, M.B. Glutathione Immobilized Polycaprolactone Nanofiber Mesh as a Dermal Drug Delivery Mechanism for Wound Healing in a Diabetic Patient. Processes 2022, 10, 512. [Google Scholar] [CrossRef]
  31. Liu, Y.; Li, C.; Feng, Z.; Han, B.; Yu, D.-G.; Wang, K. Advances in the Preparation of Nanofiber Dressings by Electrospinning for Promoting Diabetic Wound Healing. Biomolecules 2022, 12, 1727. [Google Scholar] [CrossRef] [PubMed]
  32. Ma, L.; Shi, X.; Zhang, X.; Li, L. Electrospinning of polycaprolacton/chitosan core-shell nanofibers by a stable emulsion system. Colloids Surf. A Physicochem. Eng. Asp. 2019, 583, 123956. [Google Scholar] [CrossRef]
  33. Ahn, H.; Gwak, H.J.; Kim, Y.M.; Yu, W.-R.; Lee, W.J.; Yeo, S.Y. Microstructure Analysis of Drawing Effect and Mechanical Properties of Polyacrylonitrile Precursor Fiber According to Molecular Weight. Polymers 2022, 14, 2625. [Google Scholar] [CrossRef] [PubMed]
  34. Pourhojat, F.; Sohrabi, M.; Shariati, S.; Mahdavi, H.; Asadpour, L. Evaluation of poly ε-caprolactone electrospun nanofibers loaded with Hypericum perforatum extract as a wound dressing. Res. Chem. Intermed. 2017, 43, 297–320. [Google Scholar] [CrossRef]
  35. Al-Musawi, S.; Albukhaty, S.; Al-Karagoly, H.; Sulaiman, G.M.; Alwahibi, M.S.; Dewir, Y.H.; Soliman, D.A.; Rizwana, H. Antibacterial Activity of Honey/Chitosan Nanofibers Loaded with Capsaicin and Gold Nanoparticles for Wound Dressing. Molecules 2020, 25, 4770. [Google Scholar] [CrossRef]
  36. Liu, M.; Zhou, Y.; Zhang, Y.; Yu, C.; Cao, S. Preparation and structural analysis of chitosan films with and without sorbitol. Food Hydrocoll. 2013, 33, 186–191. [Google Scholar] [CrossRef]
  37. Mosallanezhad, P.; Nazockdast, H.; Ahmadi, Z.; Rostami, A. Fabrication and characterization of polycaprolactone/chitosan nanofibers containing antibacterial agents of curcumin and ZnO nanoparticles for use as wound dressing. Front. Bioeng. Biotechnol. 2022, 10, 1797. [Google Scholar] [CrossRef]
  38. Tao, F.; Cheng, Y.; Tao, H.; Jin, L.; Wan, Z.; Dai, F.; Xiang, W.; Deng, H. Carboxymethyl chitosan/sodium alginate-based micron-fibers fabricated by emulsion electrospinning for periosteal tissue engineering. Mater. Des. 2020, 194, 108849. [Google Scholar] [CrossRef]
  39. Pawar, H.A.; Gavasane, A.J.; Choudhary, P.D. Extraction of polysaccharide from fruits of Cordia dichotoma G. Forst using acid precipitation method and its physicochemical characterization. Int. J. Biol. Macromol. 2018, 115, 871–875. [Google Scholar] [CrossRef]
  40. Suwantong, O. Biomedical applications of electrospun polycaprolactone fiber mats. Polym. Adv. Technol. 2016, 27, 1264–1273. [Google Scholar] [CrossRef]
  41. Allafchian, A.; Jalali, S.A.H.; Mousavi, S.E.; Hosseini, S.S. Preparation of cell culture scaffolds using polycaprolactone/quince seed mucilage. Int. J. Biol. Macromol. 2020, 155, 1270–1276. [Google Scholar] [CrossRef] [PubMed]
  42. Benhabiles, M.S.; Salah, R.; Lounici, H.; Drouiche, N.; Goosen, M.F.A.; Mameri, N. Antibacterial activity of chitin, chitosan and its oligomers prepared from shrimp shell waste. Food Hydrocoll. 2012, 29, 48–56. [Google Scholar] [CrossRef]
  43. Mohamed, A.E.; Elgammal, W.E.; Eid, A.M.; Dawaba, A.M.; Ibrahim, A.G.; Fouda, A.; Hassan, S.M. Synthesis and characterization of new functionalized chitosan and its antimicrobial and in-vitro release behavior from topical gel. Int. J. Biol. Macromol. 2022, 207, 242–253. [Google Scholar] [CrossRef] [PubMed]
  44. Xie, W.; Xu, P.; Wang, W.; Liu, Q. Preparation and antibacterial activity of a water-soluble chitosan derivative. Carbohydr. Polym. 2002, 50, 35–40. [Google Scholar] [CrossRef]
  45. Abd El-Hack, M.E.; El-Saadony, M.T.; Shafi, M.E.; Zabermawi, N.M.; Arif, M.; Batiha, G.E.; Khafaga, A.F.; Abd El-Hakim, Y.M.; Al-Sagheer, A.A. Antimicrobial and antioxidant properties of chitosan and its derivatives and their applications: A review. Int. J. Biol. Macromol. 2020, 164, 2726–2744. [Google Scholar] [CrossRef]
  46. Seyedian, R.; Isavi, F.; Najafiasl, M.; Zaeri, S. Electrospun fibers loaded with Cordia myxa L. fruit extract: Fabrication, characterization, biocompatibility and efficacy in wound healing. J. Drug Deliv. Sci. Technol. 2021, 63, 102528. [Google Scholar] [CrossRef]
  47. Stasiuk, M.; Kozubek, A. Biological activity of phenolic lipids. Cell. Mol. Life Sci. 2010, 67, 841–860. [Google Scholar] [CrossRef]
  48. Hamdia, M.S.; Al-Faraji, A.S. Evaluation of inhibitory activity of Cordia myxa fruit extract on microorganisms that causes spoilage of food and its role in the treatment of certain disease states. Evaluation 2017, 7, 2224–3208. [Google Scholar]
  49. Angammana, C.J.; Jayaram, S.H. Fundamentals of electrospinning and processing technologies. Part. Sci. Technol. 2016, 34, 72–82. [Google Scholar] [CrossRef]
  50. Yee Kuen, C.; Masarudin, M.J. Chitosan Nanoparticle-Based System: A New Insight into the Promising Controlled Release System for Lung Cancer Treatment. Molecules 2022, 27, 473. [Google Scholar] [CrossRef]
  51. Alzubaidi, A.K.; Al-Kaabi, W.J.; Ali, A.A.; Albukhaty, S.; Al-Karagoly, H.; Sulaiman, G.M.; Asiri, M.; Khane, Y. Green Synthesis and Characterization of Silver Nanoparticles Using Flaxseed Extract and Evaluation of Their Antibacterial and Antioxidant Activities. Appl. Sci. 2023, 13, 2182. [Google Scholar] [CrossRef]
  52. Al-Khafaji, S.A.; Alsaadawi, M.A.; Al-Yasari, A.M.; Al-Saadawe, M.A. Article review: Cordia myxa L.: The gift of the nature, A Review. Basrah J. Agric. Sci. 2021, 34, 267–277. [Google Scholar] [CrossRef]
  53. El-Massry, K.F.; Farouk, A.; Mahmoud, K.F.; El-Ghorab, A.H.; Musa, A.; Mostafa, E.M.; Ghoneim, M.M.; Naguib, I.A.; Abdelgawad, M.A. Chemical characteristics and targeted encapsulated Cordia myxa fruits extracts nanoparticles for antioxidant and cytotoxicity potentials. Saudi J. Biol. Sci. 2021, 28, 5349–5358. [Google Scholar] [CrossRef] [PubMed]
  54. Karim, A.M.; Kavehpour, H.P. Effect of Viscous Force on Dynamic Contact Angle Measurement Using Wilhelmy Plate Method. Colloids Surf. A Physicochem. Eng. Asp. 2018, 548, 54–60. [Google Scholar] [CrossRef]
Molecules 28 02501 g001 550
Figure 1. (A) SEM images of morphology characterization of different fibrous substrates of PCL (12% w/v) nanofibers, diameter 97 ± 7 nm, respectively. (B) SEM images of PCL (12% w/v) and CH (2% w/v) nanofibers, diameter 197 ± 23 nm, respectively. (C) SEM images of PCL (12% w/v) and CH (2% w/v), CMF (5% w/v) nanofibers, diameter 295 ± 78 nm, respectively.
Figure 1. (A) SEM images of morphology characterization of different fibrous substrates of PCL (12% w/v) nanofibers, diameter 97 ± 7 nm, respectively. (B) SEM images of PCL (12% w/v) and CH (2% w/v) nanofibers, diameter 197 ± 23 nm, respectively. (C) SEM images of PCL (12% w/v) and CH (2% w/v), CMF (5% w/v) nanofibers, diameter 295 ± 78 nm, respectively.
Molecules 28 02501 g001
Molecules 28 02501 g002 550
Figure 2. XRD patterns for polycaprolactone (PCL), Cordia myxa fruit extract (CMFE), and PCL/CH/CMFE composite nanofibers.
Figure 2. XRD patterns for polycaprolactone (PCL), Cordia myxa fruit extract (CMFE), and PCL/CH/CMFE composite nanofibers.
Molecules 28 02501 g002
Molecules 28 02501 g003 550
Figure 3. FTIR spectra of polycaprolactone (PCL), chitosan (CH). Cordia myxa fruit extract (CMFE), and PCL/CH/CMFE composite nanofibers.
Figure 3. FTIR spectra of polycaprolactone (PCL), chitosan (CH). Cordia myxa fruit extract (CMFE), and PCL/CH/CMFE composite nanofibers.
Molecules 28 02501 g003
Molecules 28 02501 g004 550
Figure 4. (A) Representative stress–strain curve of pure PCL (B) PCL/CH containing CMFE.
Figure 4. (A) Representative stress–strain curve of pure PCL (B) PCL/CH containing CMFE.
Molecules 28 02501 g004
Molecules 28 02501 g005 550
Figure 5. Contact angle characterization of the nanofibrous membranes.
Figure 5. Contact angle characterization of the nanofibrous membranes.
Molecules 28 02501 g005
Molecules 28 02501 g006 550
Figure 6. Cumulative extract release from PCL/chitosan 3% mats. Extract concentrations were measured at different intervals in the PBS buffer solution (n = 3).
Figure 6. Cumulative extract release from PCL/chitosan 3% mats. Extract concentrations were measured at different intervals in the PBS buffer solution (n = 3).
Molecules 28 02501 g006
Molecules 28 02501 g007 550
Figure 7. Antibacterial activity of PCL/CH/CMF fibrous scaffold.
Figure 7. Antibacterial activity of PCL/CH/CMF fibrous scaffold.
Molecules 28 02501 g007
Molecules 28 02501 g008 550
Figure 8. Viability test results (%) for fibroblast cell lines cultured for 24, 48, and 72 h with clear PCL, PCL/CH, and PCL/CH/CMFE mats. The mean and standard deviation are shown as bars (n = 5).
Figure 8. Viability test results (%) for fibroblast cell lines cultured for 24, 48, and 72 h with clear PCL, PCL/CH, and PCL/CH/CMFE mats. The mean and standard deviation are shown as bars (n = 5).
Molecules 28 02501 g008
Molecules 28 02501 g009 550
Figure 9. Images represent Cordia myxa tree (A) and its fruits (B).
Figure 9. Images represent Cordia myxa tree (A) and its fruits (B).
Molecules 28 02501 g009
Table
Table 1. The electrospinning settings of fabricated fibrous mats.
Table 1. The electrospinning settings of fabricated fibrous mats.
Selected SpecimenConc.Feed RateT.C.DVolt
PCL12%0.51820
PCL/CH12% + 2%0.52025
PCL/CH/CMFE 12% + 2% + 5%0.52120
Table
Table 2. Mechanical properties of nanofiber mesh (PCL and PCL/CH/CMFE).
Table 2. Mechanical properties of nanofiber mesh (PCL and PCL/CH/CMFE).
SampleExtension (mm)Tensile Modulus (MPa)Stress (MPa)Porosity (%)Thickness
PCL pure21.522722.49224.893176.90.027
PCL/CH/CMFE19.537220.58720.110769.20.030
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Alyamani, A.A.; Al-Musawi, M.H.; Albukhaty, S.; Sulaiman, G.M.; Ibrahim, K.M.; Ahmed, E.M.; Jabir, M.S.; Al-Karagoly, H.; Aljahmany, A.A.; Mohammed, M.K.A. Electrospun Polycaprolactone/Chitosan Nanofibers Containing Cordia myxa Fruit Extract as Potential Biocompatible Antibacterial Wound Dressings. Molecules 2023, 28, 2501. https://doi.org/10.3390/molecules28062501

AMA Style

Alyamani AA, Al-Musawi MH, Albukhaty S, Sulaiman GM, Ibrahim KM, Ahmed EM, Jabir MS, Al-Karagoly H, Aljahmany AA, Mohammed MKA. Electrospun Polycaprolactone/Chitosan Nanofibers Containing Cordia myxa Fruit Extract as Potential Biocompatible Antibacterial Wound Dressings. Molecules. 2023; 28(6):2501. https://doi.org/10.3390/molecules28062501

Chicago/Turabian Style

Alyamani, Amal A., Mastafa H. Al-Musawi, Salim Albukhaty, Ghassan M. Sulaiman, Kadhim M. Ibrahim, Elsadig M. Ahmed, Majid S. Jabir, Hassan Al-Karagoly, Abed Alsalam Aljahmany, and Mustafa K. A. Mohammed. 2023. "Electrospun Polycaprolactone/Chitosan Nanofibers Containing Cordia myxa Fruit Extract as Potential Biocompatible Antibacterial Wound Dressings" Molecules 28, no. 6: 2501. https://doi.org/10.3390/molecules28062501

APA Style

Alyamani, A. A., Al-Musawi, M. H., Albukhaty, S., Sulaiman, G. M., Ibrahim, K. M., Ahmed, E. M., Jabir, M. S., Al-Karagoly, H., Aljahmany, A. A., & Mohammed, M. K. A. (2023). Electrospun Polycaprolactone/Chitosan Nanofibers Containing Cordia myxa Fruit Extract as Potential Biocompatible Antibacterial Wound Dressings. Molecules, 28(6), 2501. https://doi.org/10.3390/molecules28062501

Article Metrics

Back to TopTop